| pubmed-article:18316548 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0278996 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0034802 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0024204 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0070948 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0040649 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C1710082 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0525010 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0086982 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C1441616 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C0040661 | lld:lifeskim |
| pubmed-article:18316548 | lifeskim:mentions | umls-concept:C1705162 | lld:lifeskim |
| pubmed-article:18316548 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18316548 | pubmed:dateCreated | 2008-3-4 | lld:pubmed |
| pubmed-article:18316548 | pubmed:abstractText | To determine the effect of tyrosine-phosphorylated signal transducer and activator of transcription 3 (pSTAT3) immunoexpression on survival in two independent cohorts of patients with squamous cell carcinoma of the head and neck (SCCHN) and to evaluate pSTAT3, transforming growth factor-alpha (TGF-alpha), epidermal growth factor receptor (EGFR), and gastrin-releasing peptide receptor (GRPR) expression in matched tumor and lymph node metastases in one of these cohorts. EXPERIMENTAL TECHNIQUE: Immunostaining for pSTAT3, TGF-alpha, EGFR, and GRPR was done in two SCCHN cohorts (cohort 1, 61 tumors; cohort 2, 69 paired primary tumors and lymph node metastases). Semiquantitative scores derived from the product of staining intensity (scale 0-3) score and percentage of positive tumor cells were correlated with clinical outcome. | lld:pubmed |
| pubmed-article:18316548 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18316548 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18316548 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18316548 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18316548 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:18316548 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:18316548 | pubmed:author | pubmed-author:ZhangQingQ | lld:pubmed |
| pubmed-article:18316548 | pubmed:author | pubmed-author:GoodingWillia... | lld:pubmed |
| pubmed-article:18316548 | pubmed:author | pubmed-author:SiegfriedJill... | lld:pubmed |
| pubmed-article:18316548 | pubmed:author | pubmed-author:GrandisJennif... | lld:pubmed |
| pubmed-article:18316548 | pubmed:author | pubmed-author:SeethalaRaja... | lld:pubmed |
| pubmed-article:18316548 | pubmed:author | pubmed-author:CollinsBobbyB | lld:pubmed |
| pubmed-article:18316548 | pubmed:author | pubmed-author:HandlerPhoebe... | lld:pubmed |
| pubmed-article:18316548 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18316548 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:18316548 | pubmed:volume | 14 | lld:pubmed |
| pubmed-article:18316548 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18316548 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18316548 | pubmed:pagination | 1303-9 | lld:pubmed |
| pubmed-article:18316548 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:meshHeading | pubmed-meshheading:18316548... | lld:pubmed |
| pubmed-article:18316548 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18316548 | pubmed:articleTitle | Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes. | lld:pubmed |
| pubmed-article:18316548 | pubmed:affiliation | Department of Otolaryngology, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA. | lld:pubmed |
| pubmed-article:18316548 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18316548 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316548 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316548 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316548 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316548 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18316548 | lld:pubmed |
